Obsidian Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Obsidian Therapeutics is a biotechnology company focused on developing controllable cell and gene therapies to improve outcomes for patients with difficult-to-treat diseases. The company uses cytoDrive technology to regulate protein expression in its therapeutic cell and gene products, aiming to enhance efficacy. Its lead program, cytoTIL15, is designed to improve the activity of tumor-infiltrating lymphocytes in solid tumors. Headquartered in Cambridge, Massachusetts, with a laboratory facility in Bedford, Massachusetts, it is mid-sized. In 2024, Obsidian Therapeutics completed a merger with Galera Therapeutics, a development that aligns its oncology-focused engineered TIL therapy pipeline for solid tumors. The organization operates in the biotechnology research industry, pursuing cell and gene therapy solutions to address areas of unmet clinical need.